Skip to main content
. 2018 Dec 18;8:17924. doi: 10.1038/s41598-018-36394-0

Figure 5.

Figure 5

The investigation of the tumor-accumulating ability of VGB4 using 2D optical imaging. (A)  After intravenous VGB4-FITC injection into BALB/c mice bearing 4T1 murine MCT, the whole body of each mouse was scanned at 0, 30, 60 and 90 minutes after injection. (B) The fluorescence intensity (in tumor region) at different times (0, 30, 60 and 90 minutes) after injection was compared to control group (untreated animals). The experiment was repeated three times. **P ≤ 0.001, compared to the control group.